patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: CEO letter to shareholders.

The letter is posted on the Pluristem website.

Share
New Message
Please login to post a reply